Chen, Yu
Wen, Heling
Huang, Zheng
Zhang, Rui
Peng, Lei
Funding for this research was provided by:
Medico-Engineering Cooperation Funds from University of Electronic Science and Technology of China (No.ZYGX2021YGLH223)
Chengdu Science and Technology Bureau (2022-YF05-01940-SN)
Article History
Received: 23 February 2024
Accepted: 20 June 2024
First Online: 25 June 2024
Declarations
:
: Not applicable.
: The Institutional Review Board and Ethics Committee of the Affiliated Tumor Hospital of Chengdu Medical College approved the study protocols and written informed participants’ consent (Ref: 36-2-1). Before enrolment, all participants provided written consent, wherein they were informed that they could freely withdraw from the study. There would be no negative consequences from opting not to participate in the study. All methods were carried out in accordance with relevant guidelines and regulations, including the Chinese Prevention of Cruelty to Human Subjects Act and the Code of Practice for the Care and Use of Human Subjects for Scientific Purposes.
: The authors declare no competing interests.